Amarex timeline for Cytodyn:.. Dec. 4th, 2014..."
Post# of 155333
(Total Views: 547)
Posted On: 10/29/2022 8:01:14 PM
Amarex timeline for Cytodyn:..
Dec. 4th, 2014..."As an expert drug and device regulatory leader, Amarex's Kazem Kazempour is appointed to George Washington University's Regulatory Affairs Advisory Board. Two months later, Cytodyn signs an agreement with ACR
12/ 21, 2017, Amarex announces successful Orphan Drug Designation request filing on behalf of Cytodyn, inc. had been granted.
12/31, 2018 Amarex celebrates 20 yrs of clinical product dev. and approvals.
03/06, 2019 Amarex sets a record for successful US FDA submissions.
10/09, 2019, A majority investment by NSF in Amarex Research, LLC
03/20, 2020 Amarex assists with EUA for Covid-19 treatment (Leronlimab).
04/02, 2020 Treating Covid-19 with Leronlimab additional patients added to EUA.
04/23, 2020 Clinical trial for Severely ill Covid-19 patients is now enrolling.
04/28, 2020 Amarex submits a BLA on behalf of Cytodyn, a product to treat HIV
05/28, 2020 Amarex co-authors paper on EU of treatment of Covid-19.
08/21, 2020 Phase 2-mild-to-moderate Covid-19 study results for Pro140.
09/02, 2020 Amarex in the fight against Covid-19, repurposed HIV drug for Covid
01/18, 2021 Severe-t-critical Covid-19 patient trial reaches full enrollment (390).
09/10. 2021 Amarex to manage phase 2 clinical study of a new therapy for LH.
KINDA makes you wonder...at what point they twisted.
Dec. 4th, 2014..."As an expert drug and device regulatory leader, Amarex's Kazem Kazempour is appointed to George Washington University's Regulatory Affairs Advisory Board. Two months later, Cytodyn signs an agreement with ACR
12/ 21, 2017, Amarex announces successful Orphan Drug Designation request filing on behalf of Cytodyn, inc. had been granted.
12/31, 2018 Amarex celebrates 20 yrs of clinical product dev. and approvals.
03/06, 2019 Amarex sets a record for successful US FDA submissions.
10/09, 2019, A majority investment by NSF in Amarex Research, LLC
03/20, 2020 Amarex assists with EUA for Covid-19 treatment (Leronlimab).
04/02, 2020 Treating Covid-19 with Leronlimab additional patients added to EUA.
04/23, 2020 Clinical trial for Severely ill Covid-19 patients is now enrolling.
04/28, 2020 Amarex submits a BLA on behalf of Cytodyn, a product to treat HIV
05/28, 2020 Amarex co-authors paper on EU of treatment of Covid-19.
08/21, 2020 Phase 2-mild-to-moderate Covid-19 study results for Pro140.
09/02, 2020 Amarex in the fight against Covid-19, repurposed HIV drug for Covid
01/18, 2021 Severe-t-critical Covid-19 patient trial reaches full enrollment (390).
09/10. 2021 Amarex to manage phase 2 clinical study of a new therapy for LH.
KINDA makes you wonder...at what point they twisted.
(5)
(0)